These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9302455)

  • 1. No effect of protease inhibitor on clinical and virological evolution of Castleman's disease in an HIV-1-infected patient.
    Dupin N; Krivine A; Calvez V; Gorin I; Franck N; Escande JP
    AIDS; 1997 Sep; 11(11):1400-1. PubMed ID: 9302455
    [No Abstract]   [Full Text] [Related]  

  • 2. Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.
    Flandre P; Peytavin G; Meiffredy V; Saidi Y; Descamps D; Delagnes M; Brun-Vézinet F; Raffi F;
    Antivir Ther; 2002 Jun; 7(2):113-21. PubMed ID: 12212923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentric Castleman's disease in a patient with HIV.
    Fowler A; Collins L; de Ruiter A; Whittaker S; Kulasegaram R; Bradbeer C
    Int J STD AIDS; 2006 Jan; 17(1):63-4. PubMed ID: 16409683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polymorphism of protease genes in patients infected with HIV-1 and response to therapy including a protease inhibitor].
    Mouroux M; Bossi P; Yvon-Groussin A; Delaugerre C; Valantin MA; Tubiana R; Coutellier A; Bonmarchand M; Bricaire F; Katlama C; Agut H; Huraux JM; Calvez V
    Pathol Biol (Paris); 1999 May; 47(5):549-52. PubMed ID: 10418038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Boonyaprawit P
    Antivir Ther; 2005; 10(8):911-6. PubMed ID: 16430196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of onychomycosis without antifungal therapy after initiation of highly active anti-retroviral therapy (HAART) in an HIV-infected patient.
    Tachikawa N; Yasuoka A; Oka S
    Jpn J Infect Dis; 1999 Dec; 52(6):245-6. PubMed ID: 10738363
    [No Abstract]   [Full Text] [Related]  

  • 7. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy.
    Jubault V; Burgard M; Le Corfec E; Costagliola D; Rouzioux C; Viard JP
    AIDS; 1998 Dec; 12(17):2358-9. PubMed ID: 9863885
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug shows potency against HIV.
    Dent Today; 1996 May; 15(5):22, 26. PubMed ID: 9567867
    [No Abstract]   [Full Text] [Related]  

  • 10. Multicentric Castleman's disease treated with combination chemotherapy and rituximab in four HIV-positive men: a case series.
    Bestawros A; Michel R; Séguin C; Routy JP
    Am J Hematol; 2008 Jun; 83(6):508-11. PubMed ID: 18027834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy.
    Galli M; Balotta C; Meroni L; Colombo MC; Papagno L; Bagnarelli P; Testa L; Varchetta S; Colombo L; Moroni M; d'Arminio Monforte A; Clerici M; Clementi M
    AIDS; 1998 Dec; 12(18):2500-2. PubMed ID: 9875591
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors that predict incomplete virological response to protease inhibitor-based antiretroviral therapy.
    Clough LA; D'Agata E; Raffanti S; Haas DW
    Clin Infect Dis; 1999 Jul; 29(1):75-81; discussion 82-4. PubMed ID: 10433568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virological treatment failure of highly active antiretroviral therapy in an unselected cohort of HIV-infected patients.
    Bonfanti P; Capetti A; Di Mattei P; Niero F; Rizzardini G
    AIDS; 1998 Jun; 12(9):1111. PubMed ID: 9662213
    [No Abstract]   [Full Text] [Related]  

  • 14. Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy.
    Blum L; Pellet C; Agbalika F; Blanchard G; Morel P; Calvo F; Lebbé C
    AIDS; 1997 Nov; 11(13):1653-5. PubMed ID: 9365774
    [No Abstract]   [Full Text] [Related]  

  • 15. Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection.
    Smith D; Berrey MM; Robertson M; Mehrotra D; Markowitz M; Perrin L; Clumeck N; Lazzarin A; Burckhardt B; Weber R; Corey L; Cooper DA
    J Infect Dis; 2000 Sep; 182(3):950-4. PubMed ID: 10950796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using ritonavir with indinavir in cases of virologic failure.
    TreatmentUpdate; 2001; 12(12):7. PubMed ID: 11570095
    [No Abstract]   [Full Text] [Related]  

  • 17. Data in from first head-to-head protease inhibitor.
    AIDS Patient Care STDS; 1998 Apr; 12(4):317. PubMed ID: 11361961
    [No Abstract]   [Full Text] [Related]  

  • 18. Indinavir gender study shows consistency.
    AIDS Patient Care STDS; 1998 Dec; 12(12):940-1. PubMed ID: 11362069
    [No Abstract]   [Full Text] [Related]  

  • 19. Uncommon hematologic malignancies. Case 1. Plasmablastic leukemia in HIV-associated multicentric Castleman's disease.
    Jung CP; Horster S; Lohse P; Bogner JR; Emmerich B; Goebel FD
    J Clin Oncol; 2003 Nov; 21(22):4248-9. PubMed ID: 14615455
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1.
    Murphy RL; Sommadossi JP; Lamson M; Hall DB; Myers M; Dusek A
    J Infect Dis; 1999 May; 179(5):1116-23. PubMed ID: 10191212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.